SLI Medical Acceptable Dating: we will ship >= 90 days
Strength
Requires Refrigeration
Type
70 U - 30 U / mL
UNSPSC Code
Subcutaneous
Volume
51183603
3 mL
Features
NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia
NovoLog Mix 70/30 is a blood glucose lowering agent with a rapid onset and an intermediate duration of action
NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection
[rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart
Presentation contains 100 Units of insulin aspart per mL (U-100)
